Memorial Sloan Kettering Gave Top Doctor $1.5 Million After He Was Forced to Resign Over Conflicts of Interest
Dr. José Baselga resigned as chief medical officer after payments he received from for-profit health care companies came to light in 2018. Then, Memorial Sloan Kettering quietly gave him a $1.5 million severance package, according to IRS documents.
Memorial Sloan Kettering Leaders Violated Conflict-of-Interest Rules, Report Finds
A policy review follows months of turmoil at the cancer center, which pledged an overhaul, including new rules on public disclosure and limits on outside profits.
Memorial Sloan Kettering Curbs Executives’ Ties to Industry After Conflict-of-Interest Scandals
The cancer center will now bar top officials from sitting on outside boards of for-profit companies, and is conducting a wide-scale review of other policies.
Top Cancer Doctor, Forced Out Over Ties to Drug Makers, Joins Their Ranks
AstraZeneca has hired Dr. José Baselga, the former chief medical officer at Memorial Sloan Kettering, to lead its cancer research unit.
Memorial Sloan Kettering’s Season of Turmoil
One of the nation’s top cancer hospitals has grappled with how to bring breakthrough treatments to market while remaining true to its mission.
Top Cancer Doctor Resigns as Editor of Medical Journal
Dr. José Baselga, the former chief medical officer of Memorial Sloan Kettering Cancer Center, was asked to resign after he failed to disclose corporate ties in dozens of scientific articles.
Doctors Aren’t Disclosing Industry Ties in Medical Journal Studies. And Journals Are Doing Little to Enforce Their Rules.
Leading medical figures have not accurately disclosed their relationships with drug companies.
Sloan Kettering Cancer Researchers Correct the Record by Revealing Company Ties
The hospital’s chief medical officer resigned last month after failing to disclose company ties in medical journals. Now, Memorial Sloan Kettering researchers, including chief executive Dr. Craig B. Thompson, are updating their own conflict-of-interest disclosures.
Memorial Sloan Kettering’s Chief Executive Resigns From Merck’s Board of Directors
Under scrutiny for the hospital’s industry ties and compensation, Dr. Craig B. Thompson stepped down from two company boards.
Cancer Center’s Board Chairman Faults Top Doctor, Saying He “Crossed Lines”
The executive told Memorial Sloan Kettering staff that the hospital did not do enough to limit the industry conflicts of its chief medical officer, who has resigned.